160 related articles for article (PubMed ID: 26547111)
1. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
[TBL] [Abstract][Full Text] [Related]
2. Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
Ito S; Wakamatsu K
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439519
[No Abstract] [Full Text] [Related]
3. 4-(4-Hydroxyphenyl)-2-butanol (rhododendrol)-induced melanocyte cytotoxicity is enhanced by UVB exposure through generation of oxidative stress.
Goto N; Tsujimoto M; Nagai H; Masaki T; Ito S; Wakamatsu K; Nishigori C
Exp Dermatol; 2018 Jul; 27(7):754-762. PubMed ID: 29630780
[TBL] [Abstract][Full Text] [Related]
4. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
[TBL] [Abstract][Full Text] [Related]
5. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
[TBL] [Abstract][Full Text] [Related]
6. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
[TBL] [Abstract][Full Text] [Related]
7. Depigmentation caused by application of the active brightening material, rhododendrol, is related to tyrosinase activity at a certain threshold.
Kasamatsu S; Hachiya A; Nakamura S; Yasuda Y; Fujimori T; Takano K; Moriwaki S; Hase T; Suzuki T; Matsunaga K
J Dermatol Sci; 2014 Oct; 76(1):16-24. PubMed ID: 25082450
[TBL] [Abstract][Full Text] [Related]
8. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CD86 and IL-12 by rhododendrol in THP-1 cells cocultured with melanocytes through ROS and ATP.
Katahira Y; Sakamoto E; Watanabe A; Furusaka Y; Inoue S; Hasegawa H; Mizoguchi I; Yo K; Yamaji F; Toyoda A; Yoshimoto T
J Dermatol Sci; 2022 Dec; 108(3):167-177. PubMed ID: 36610941
[TBL] [Abstract][Full Text] [Related]
10. Anti-Pigmentation Effects of Eight
Ahn HY; Choo YM; Cho YS
J Microbiol Biotechnol; 2018 Mar; 28(3):375-380. PubMed ID: 29316744
[TBL] [Abstract][Full Text] [Related]
11. Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6,7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity.
Ito S; Ojika M; Yamashita T; Wakamatsu K
Pigment Cell Melanoma Res; 2014 Sep; 27(5):744-53. PubMed ID: 24903082
[TBL] [Abstract][Full Text] [Related]
12. Rhododenol and raspberry ketone impair the normal proliferation of melanocytes through reactive oxygen species-dependent activation of GADD45.
Kim M; Baek HS; Lee M; Park H; Shin SS; Choi DW; Lim KM
Toxicol In Vitro; 2016 Apr; 32():339-46. PubMed ID: 26867644
[TBL] [Abstract][Full Text] [Related]
13. Rhododenol Activates Melanocytes and Induces Morphological Alteration at Sub-Cytotoxic Levels.
Kim M; Lee CS; Lim KM
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726751
[TBL] [Abstract][Full Text] [Related]
14. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
Nishimaki-Mogami T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
[TBL] [Abstract][Full Text] [Related]
15. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
[TBL] [Abstract][Full Text] [Related]
16. Tyrosinase-catalyzed metabolism of rhododendrol (RD) in B16 melanoma cells: production of RD-pheomelanin and covalent binding with thiol proteins.
Ito S; Okura M; Nakanishi Y; Ojika M; Wakamatsu K; Yamashita T
Pigment Cell Melanoma Res; 2015 May; 28(3):295-306. PubMed ID: 25713930
[TBL] [Abstract][Full Text] [Related]
17. The potential depigmenting activity of retinaldehyde.
Sorg O; Kasraee B; Salomon D; Saurat JH
Dermatology; 2013; 227(3):231-7. PubMed ID: 24080511
[TBL] [Abstract][Full Text] [Related]
18. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
[TBL] [Abstract][Full Text] [Related]
19. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.
Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426
[TBL] [Abstract][Full Text] [Related]
20. Depigmentation of the skin induced by 4-(4-hydroxyphenyl)-2-butanol is spontaneously re-pigmented in brown and black guinea pigs.
Kuroda Y; Takahashi Y; Sakaguchi H; Matsunaga K; Suzuki T
J Toxicol Sci; 2014 Aug; 39(4):615-23. PubMed ID: 25056786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
